ONC trade ideas
Once buyDidnt break to the downside, start of a new bullish trend, going for a second Elliot wave, bullish market structure, reaction at the support line
ONCY: Daily VCPSetup: RocketBase
VCP: 9W 38/4 4T
RS: 89
The posted chart contains a VCP (volatility contraction pattern). The first label "W" stands for weekly and shows the duration of the entire consolidation. In the middle label, the percentage of contractions is indicated (for example, "15/4"), with 15 representing the -15% depth of the base and 4 representing -4% of the last contraction. The last part "T" represents the number of contractions. The light blue lines in the chart correspond to the contractions. A more detailed description can be found in Mark Minervini's books.
RS stands for relative strength and measures the strength of the stock compared to the overall market. The value range is 1-99 with 99 being the highest value. The rank was generated by fyntrade.
ONCY: Bullish Pennant (51%)Bullish Pennant (51%)
Pros:
Volume during post formation
Descending volume during triangle formation
Golden cross in blue
PPS above 50MA and 200MA
RS above 0
R/R ratio above 5
ATR ascending
250RSI above 50 and ascending
200MA ascending
Cona:
RS Flat
Target:
PT = 5.45$
Help how ever you can to keep this alive.
Thank you to those who have donated Coins!
Always do your own due dilligence. This is not financial advice
Stay Humble, have fun, make money!
Education:
www.dailyfx.com
$ONCY initiated with a Buy at H.C. Wainwright -302.14% potentialOncolytics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Patrick Trucchio initiated coverage of Oncolytics Biotech with a Buy rating and $15 price target. The company is "on the cusp of demonstrating potential to upend the treatment paradigms of several cancers," Trucchio tells investors in a research note. He believes Oncolytics is well positioned for the "oncolytic virus trend."
The price target was set to $ 15.00. At a current price of $ 3.73 there is upside potential of 302.14%.
ONCY: Another risky biotech to considerLong term downtrend line broken. V shaped upswing with much increased volume. It has a well patented potential product that has great promise in assisting in treatment of difficult cancers. Like all small biotech companies there is often a lot of volatility and risk. I'm looking for a rise to 9-15. Yesterday jump due to Buy rating with target of 15 by HC Wainwright & Co
www.benzinga.com
More info at : seekingalpha.com
ONCY - Long SetupCould flag again if it breaks above 3.66. Stop signal 3.19. Smaller position to offset stop risk. Target 4.23(acorn is already holding an active position in this)
ONC.CA: Descending TriangleDescending Triangle
Pros:
Descending Volume
R/R Ratio above 9
Descending ATR
200MA flat/ascending
PPS below 50MA
Cons:
250RSI still close to 50
PPS above 200MA
If confirmed
PT1 = 2,10
PT2 = 1,43
PT3 = 0,95
Bonus PT4 = 0,75
ONCY LONGMore information was necessary to form this decision. Time and patience. ONCY has stayed in the ascending channel well. I will buy here, but this is not financial advice.
ONCY Bull flagI can see people getting frustrated with ONCY so here is a little technical analysis .
ONCY long ideaThis has room to move down within the ascending channel, but is on a level of horizontal support right now. Just keeping levels in mind. I will likely buy a small position here and will add more if it reaches the low of the channel. Happy trading!
ONCY longStrictly technical analysis and NOT financial advice. Broke 100MA and horizontal resistance and retested both.
Three Percent Trade Idea: Go long ONCYHere is a great opportunity to go long on ONCY .
At Three Percent Trades we have a price target of $4.00 - $7.00 / share, which is a potential upside of 52 - 167% from the current level.
We use a combination of fundamentals & technical analysis to trade high probability set-ups, and believe this is a great opportunity to take advantage.
$ONCY upside targets Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.
$ONCY Oncolytics Biotech, Inc 25 % upside
On the verge of breaking the 100ma resistance which sits in confluence withe .382 fib as current barrier to a bullish move higher.25% upside
Possible
Average analysts price target $6.93 and BUY rating
Company profile
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.
bullish reversal! I hope its God speKING not the devil. I hope its God speKING not the devil. Cos you can never be too sure of the market.. However it looks like TEXTBOOK reversal
ONC - Bullish Its been range trading for a while and is poking its head. Gap over head. RSI uprending. Like it
ONCYONCY = TIME TO TOURN UP = FINAL CICLE IN ACCUMULATION BOTTOM AREA FROM 1,5 - 1,75 $ ... THIS IS AREA OF INVESTING ...
Make or break me... do or dieAbove ema 20 at 76.4 on daily... (A nice fib number too) and the stock will move. Might have to see the middle BB giving support before move.
It's a heavily traded handle.
Safe trading ladies & gents!
@BLawrenceM
I have moved on to do many of my publications on my Twitter account due to the easier and much quicker way of making follow up charts. Follow me there if it suits you.
Music at work:
www.youtube.com
open.spotify.com
